Mahboobeh Ghasemzadeh Rahbardar

Dr. Mahboobeh Ghasemzadeh Rahbardar

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

5 September 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
JJJalileh Jalali
Jalileh Jalali
MRMahboobeh Ghasemzadeh Rahbardar
Mahboobeh Ghasemzadeh Rahbardar

4 June 2021 in Nutrition and Cancer
Verified
Journal Article
Closed access
MRMahboobeh Ghasemzadeh Rahbardar
Mahboobeh Ghasemzadeh Rahbardar
FEFarhad Eisvand
Farhad Eisvand
MRMaryam Rameshrad
Maryam Rameshrad
BRBibi Marjan Razavi
Bibi Marjan Razavi
HHHossein Hosseinzadeh
Hossein Hosseinzadeh
Doxorubicin (DOX) is an anticancer medicine that may trigger cardiomyopathy. Rosmarinic acid (RA) has shown antioxidant, anti-inflammatory, and anticancer effects. This investigation assessed the cardioprotective effect of RA on DOX-induced-toxicity in both in vivo and in vitro experiments. Male rats were randomized on 7 groups: (1) control, (2) DOX (2 mg/kg, per 48 h, 12d, i.p), (3) RA (40 mg/kg, 12d, i.p.), (4–6) RA (10, 20, 40 mg/kg, 16d, i.p.)+ DOX, (7) Vitamin E (200 mg/kg, per 48 h, 16d, i.p.) + DOX and then indices of cardiac function were estimated. Also, DOX and rosmarinic acid effects were examined on MCF7 cells (breast cancer cells line) to clarify that both cardiotoxicity and anticancer effects were analyzed. DOX increased heart to body weight ratio, RRI, QA, STI, QRS duration and voltage, attenuated HR, blood pressure, Max dP/dt, Min dP/dt, LVDP, enhanced MDA, declined GSH amount, and caused fibrosis and necrosis in cardiac tissue. Administration of RA ameliorated the toxic effects of DOX. In vitro studies showed that RA did not affect the cytotoxic effect of DOX. RA as an antioxidant, anti-inflammatory, and cardioprotective compound could be a promising compound to help minimize DOX-induced cardiotoxicity.

2 March 2022 in Phytotherapy Research
Verified
Journal Article
Closed access
NNNahid Najafi
Nahid Najafi
SMSoghra Mehri
Soghra Mehri
MRMahboobeh Ghasemzadeh Rahbardar
Mahboobeh Ghasemzadeh Rahbardar
HHHossein Hosseinzadeh
Hossein Hosseinzadeh

27 December 2021 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
FEFarhad Eisvand
Farhad Eisvand
MIMohsen Imenshahidi
Mohsen Imenshahidi
MRMahboobeh Ghasemzadeh Rahbardar
Mahboobeh Ghasemzadeh Rahbardar
SYSeyed Abbas Tabatabaei Yazdi
Seyed Abbas Tabatabaei Yazdi
MRMaryam Rameshrad
Maryam Rameshrad
HHHossein Hosseinzadeh
Hossein Hosseinzadeh

31 October 2023 in Heliyon
Verified
Journal Article
Open access
KNKarim Naraki
Karim Naraki
MRMahboobeh Ghasemzadeh Rahbardar
Mahboobeh Ghasemzadeh Rahbardar
BABasiru Olaitan Ajiboye
Basiru Olaitan Ajiboye
HHHossein Hosseinzadeh
Hossein Hosseinzadeh
(s): Metabolic syndrome is a collection of metabolic abnormalities that includes hyperglycemia, dyslipidemia, hypertension, and obesity. Ellagic acid is found in various fruits and vegetables. It has been reported to have several pharmacological properties, such as antibacterial, antifungal, antiviral, anti-inflammatory, hepatoprotective, cardioprotective, chemopreventive, neuroprotective, gastroprotective, and antidiabetic. Our current study aims to shed light on the probable efficiency of ellagic acid in managing metabolic syndrome and its complications. To prepare the present review, the databases or search engines utilized included Scopus, PubMed, Science Direct, and Google Scholar, and relevant articles have been gathered with no time limit until March 2023. Several investigations indicated that ellagic acid could be a potent compound for the treatment of many disorders such as diabetes, hypertension, and hyperlipidemia by various mechanisms, including increasing insulin secretion, insulin receptor substrate protein 1 expression, regulating glucose transporter 4, triglyceride, total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), attenuating tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), reactive oxygen species (ROS), malondialdehyde (MDA), and oxidative stress in related tissues. Furthermore, ellagic acid ameliorates mitochondrial function, upregulates uncoupling protein 1 (found in brown and white adipose tissues), and regulates blood levels of nitrate/nitrite and vascular relaxations in response to acetylcholine and sodium nitroprusside. Ellagic acid can treat or manage metabolic syndrome and associated complications, according to earlier studies. To validate the beneficial effects of ellagic acid on metabolic syndrome, additional preclinical and clinical research is necessary.